Skip to main content
Year archive

PARADIGM BIOPHARMACEUTICALS LIMITED.. — 2023 filings

All 74 regulatory filings released by PARADIGM BIOPHARMACEUTICALS LIMITED.. (PAR) in 2023, sourced directly from the official regulator.

74 Filings
2023 Period
2023 filings (74)
Filing Released Lang
Change in substantial holding 2 pages 251.4KB
Major Shareholding Notification
2023-12-05 English
Change of Director's Interest Notice - Fisher 2 pages 200.4KB
Director's Dealing
2023-11-30 English
Application for quotation of securities - PAR 6 pages 27.7KB
Share Issue/Capital Change
2023-11-29 English
Notification of cessation of securities - PAR 4 pages 23.7KB
Transaction in Own Shares
2023-11-29 English
Change of Director's Interest Notice - Rennie 4 pages 213.2KB
Director's Dealing
2023-11-29 English
2023 AGM Chairman Address 4 pages 109.6KB
AGM Information
2023-11-28 English
2023 AGM Company Update 25 pages 5.9MB
AGM Information
2023-11-28 English
Results of Meeting 3 pages 300.4KB
Declaration of Voting Results & Voting Rights Announcements
2023-11-28 English
Security Class Reinstatement to Quotation PARO 1 pa
Regulatory Filings
2023-11-27 English
Application for quotation of securities - PAR 8 pages 32.7KB
Capital/Financing Update
2023-11-26 English
Listing of Options - Top 20 Holders and Distribution Reports 3 pages 84.2KB
Major Shareholding Notification
2023-11-26 English
Successful completion of Retail Entitlement Offer 3 pages 160.5KB
Capital/Financing Update
2023-11-22 English
Security Class Suspension from Quotation PARO 1 pag
Regulatory Filings
2023-11-20 English
PAR Pre-AGM Update 3 pages 184.4KB
AGM Information
2023-11-19 English
Application for quotation of securities - PAR 6 pages 27.1KB
Share Issue/Capital Change
2023-11-19 English
Notice of release of escrowed securities 1 page 297
Share Issue/Capital Change
2023-11-09 English
Application for quotation of securities - PAR 7 pages 30.3KB
Share Issue/Capital Change
2023-11-07 English
Retail Entitlement Offer Open 4 pages 147.5KB
Capital/Financing Update
2023-11-05 English
Addendum to Notice of Meeting 49 pages 779.7KB
AGM Information
2023-11-02 English
Paradigm to Recommence Trading 1 page 87.9KB
Regulatory Filings
2023-10-31 English
PAR Successful Placement and Fully Underwritten ANREO 6 pages 172.5KB
Capital/Financing Update
2023-10-30 English
Replacement Entitlement Offer and Placement Prospectus 55 pages 759.1KB
Capital/Financing Update
2023-10-30 English
Update - Proposed issue of securities - PAR 14 pages 54.9KB
Capital/Financing Update
2023-10-30 English
Proposed issue of securities - PAR 7 pages 33.9KB
Capital/Financing Update
2023-10-30 English
Trading Halt 2 pages 279.0KB
Capital/Financing Update
2023-10-29 English
Quarterly Activities/Appendix 4C Cash Flow Report 11 pages 387.8KB
Interim / Quarterly Report Q1 2024
2023-10-29 English
Paradigm Launches $30M Capital Raising 6 pages 197.3KB
Capital/Financing Update
2023-10-29 English
Investor Presentation - $30m Capital Raise 38 pages 11.4MB
Capital/Financing Update
2023-10-29 English
Proposed issue of securities - PAR 15 pages 54.5KB
Capital/Financing Update
2023-10-29 English
Entitlement Offer and Placement Prospectus 49 pages 697.2KB
Capital/Financing Update
2023-10-29 English
Update - Proposed issue of securities - PAR 14 pages 52.5KB
Capital/Financing Update
2023-10-29 English
Notice of Annual General Meeting/Proxy Form 38 pages 507.2KB
AGM Information
2023-10-24 English
Final Director's Interest Notice 2 pages 170.0KB
Director's Dealing
2023-10-22 English
Resignation of Non-executive Director 1 page 90.3KB
Board/Management Information
2023-10-19 English
iPPS Increases Cartilage Thickness in Phase 2 Trial 38 pages 7.1MB
Regulatory Filings
2023-10-17 English
Trading Halt 2 pages 262.6KB
Regulatory Filings
2023-10-15 English
iPPS SIGNIFICANT OA PAIN REDUCTION AT 12 MONTHS 32 pages 7.8MB
Capital/Financing Update
2023-10-09 English
Trading Halt 2 pages 274.4KB
Regulatory Filings
2023-10-05 English
Date of AGM & Closing Date for Director Nominations 1
AGM Information
2023-10-02 English
Change of Share Registry Details 1 page 282.4KB
Regulatory Filings
2023-09-21 English
Application for quotation of securities - PAR 6 pages 27.1KB
Share Issue/Capital Change
2023-09-12 English
Paradigm Accepted for Presentations at Major Conferences 3 pages 183.6KB
Regulatory Filings
2023-08-31 English
Notice of release of escrowed securities 1 page 297
Share Issue/Capital Change
2023-08-31 English
Appendix 4G 12 pages 362.5KB
Governance Information
2023-08-31 English
Corporate Governance Statement 15 pages 334.5KB
Governance Information
2023-08-31 English
2023 Annual Report and Appendix 4E 70 pages 3.6MB
Regulatory Filings
2023-08-24 English
Quarterly Activities/Appendix 4C Cash Flow Report 10 pages 459.1KB
Interim / Quarterly Report Q4 2023
2023-07-30 English
Study demonstrates Bene PPS is unique 2 pages 155.1KB
Regulatory Filings
2023-07-26 English
Application for quotation of securities - PAR 6 pages 27.1KB
Capital/Financing Update
2023-07-19 English
Notice of release of escrowed securities 1 page 297
Regulatory Filings
2023-07-09 English
PAR Reports Phase 3 Clinical Trial Update 4 pages 200.2KB
Regulatory Filings
2023-07-03 English
Notification of cessation of securities - PAR 5 pages 26.1KB
Transaction in Own Shares
2023-06-28 English
Primary and Secondary endpoints met in MPS I Trial 3 pages 188.5KB
Regulatory Filings
2023-06-05 English
iPPS shows 3-year equivalent durability in OA Canine Study 6 pages 436.5KB
Regulatory Filings
2023-05-31 English
Change of Director's Interest Notice - Fisher 2 pages 198.3KB
Director's Dealing
2023-05-21 English
Change of Director's Interest Notice - Rennie 4 pages 205.9KB
Director's Dealing
2023-05-16 English
PAR Phase 2 MPS VI clinical trial completes enrolment 4 pages 260.9KB
Capital/Financing Update
2023-04-27 English
Quarterly Activities/Appendix 4C Cash Flow Report 10 pages 336.6KB
Interim / Quarterly Report Q3 2023
2023-04-27 English
iPPS Demonstrates Multiple DMOAD Signals in Phase 2 Study 28 pages 6.0MB
Investor Presentation
2023-04-03 English
Trading Halt 2 pages 642.7KB
Regulatory Filings
2023-03-30 English
PAR Poster Presentation to OARSI World Congress 2023 3 pages 527.8KB
Investor Presentation
2023-03-27 English
Notification of cessation of securities - PAR 5 pages 26.4KB
Share Issue/Capital Change
2023-03-26 English
NWR Virtual Healthcare Conference Presentation 18 pages 5.1MB
Investor Presentation
2023-03-21 English
Paradigm to present at the NWR Virtual Healthcare Conference 2 pages 124.5KB
Investor Presentation
2023-03-20 English
PAR Receives European Regulatory and Ethics Approval 3 pages 150.6KB
Regulatory Filings
2023-03-13 English
Change of Chief Financial Officer 2 pages 139.5KB
Board/Management Information
2023-03-02 English
Notification of cessation of securities - PAR 4 pages 24.3KB
Share Issue/Capital Change
2023-03-01 English
Half Yearly Report and Accounts 26 pages 2.4MB
Regulatory Filings
2023-02-26 English
Paradigm Increases Presence at OARSI World Congress 2023 2 pages 119.6KB
Investor Presentation
2023-02-01 English
Quarterly Activities/Appendix 4C Cash Flow Report 10 pages 451.4KB
Interim / Quarterly Report Q2 2023
2023-01-30 English
Application for quotation of securities - PAR 6 pages 27.0KB
Share Issue/Capital Change
2023-01-30 English
Notice of release of escrowed securities 1 page 252
Share Issue/Capital Change
2023-01-18 English
Paradigm Presentation to JP Morgan Healthcare Conference 21 pages 7.0MB
Investor Presentation
2023-01-10 English
Appendix 4G & 2022 Corporate Governance Statement 27 pages 466.6KB
Regulatory Filings
2023-01-09 English